risedronic acid has been researched along with Hyperkyphosis in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perkins, AC | 1 |
| Frier, M | 1 |
| Blackshaw, PE | 1 |
| Spiller, RC | 1 |
| Fairbairn, KJ | 1 |
| Dansereau, RJ | 1 |
| Kinghorn, T | 1 |
| San, P | 1 |
| Hosking, D | 1 |
1 trial available for risedronic acid and Hyperkyphosis
| Article | Year |
|---|---|
Esophageal transit of the weekly film-coated risedronate (Actonel) placebo tablet in subjects with Kyphosis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density Conservation Agents; Esophagus; Etidroni | 2006 |